A phase 1, first-in-human, open label, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of stabilized isoamyl nitrite nasal spray in healthy adult participants
Titel:
A phase 1, first-in-human, open label, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of stabilized isoamyl nitrite nasal spray in healthy adult participants
Auteur:
Cassie, David Mirceta, Mila Tian, Jing Bellani, Melisa Juanitez, Erika McLeod, Jessica Komlenovic, Vanja Drobic, Bojan Warnock, Bob Savransky, Vladimir Artym, Vira Hill, Daniel Holstege, Christopher Punch, Jerry Smith, William Wyatt, David
Verschenen in:
Journal of pharmacology and experimental therapeutics